Huntington National Bank’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.15M | Buy |
6,041
+1,250
| +26% | +$235K | 0.01% | 509 |
|
|
2026
Q1 | $945K | Buy |
4,791
+313
| +7% | +$60.4K | 0.01% | 523 |
|
|
2025
Q4 | $823K | Sell |
4,478
-367
| -8% | -$64.4K | ﹤0.01% | 480 |
|
|
2025
Q3 | $743K | Sell |
4,845
-139
| -3% | -$21K | ﹤0.01% | 482 |
|
|
2025
Q2 | $696K | Sell |
4,984
-273
| -5% | -$38.3K | ﹤0.01% | 478 |
|
|
2025
Q1 | $773K | Sell |
5,257
-1,481
| -22% | -$214K | 0.01% | 455 |
|
|
2024
Q4 | $883K | Sell |
6,738
-212
| -3% | -$29.7K | 0.01% | 437 |
|
|
2024
Q3 | $1.08M | Buy |
6,950
+511
| +8% | +$82.5K | 0.01% | 410 |
|
|
2024
Q2 | $1M | Buy |
6,439
+2,033
| +46% | +$306K | 0.01% | 411 |
|
|
2024
Q1 | $597K | Buy |
4,406
+398
| +10% | +$52.7K | ﹤0.01% | 466 |
|
|
2023
Q4 | $540K | Sell |
4,008
-798
| -17% | -$104K | ﹤0.01% | 471 |
|
|
2023
Q3 | $651K | Sell |
4,806
-393
| -8% | -$53.7K | 0.01% | 439 |
|
|
2023
Q2 | $744K | Buy |
5,199
+729
| +16% | +$107K | 0.01% | 427 |
|
|
2023
Q1 | $620K | Sell |
4,470
-143
| -3% | -$19.2K | 0.01% | 444 |
|
|
2022
Q4 | $625K | Buy |
4,613
+18
| +0.4% | +$2.26K | 0.01% | 433 |
|
|
2022
Q3 | $504K | Buy |
4,595
+196
| +4% | +$24.9K | 0.01% | 461 |
|
|
2022
Q2 | $581K | Sell |
4,399
-74
| -2% | -$9.71K | 0.01% | 447 |
|
|
2022
Q1 | $593K | Buy |
4,473
+906
| +25% | +$109K | 0.01% | 457 |
|
|
2021
Q4 | $416K | Buy |
3,567
+1,485
| +71% | +$175K | ﹤0.01% | 519 |
|
|
2021
Q3 | $250K | Buy |
2,082
+298
| +17% | +$34.7K | ﹤0.01% | 567 |
|
|
2021
Q2 | $214K | Sell |
1,784
-309
| -15% | -$33.9K | ﹤0.01% | 604 |
|
|
2021
Q1 | $208K | Sell |
2,093
-50
| -2% | -$5.03K | ﹤0.01% | 513 |
|
|
2020
Q4 | $215K | Sell |
2,143
-817
| -28% | -$86.5K | ﹤0.01% | 483 |
|
|
2020
Q3 | $325K | Sell |
2,960
-63
| -2% | -$7.01K | ﹤0.01% | 421 |
|
|
2020
Q2 | $320K | Sell |
3,023
-48
| -2% | -$4.96K | 0.01% | 419 |
|
|
2020
Q1 | $275K | Sell |
3,071
-382
| -11% | -$36K | 0.01% | 435 |
|
|
2019
Q4 | $344K | Buy |
3,453
+1,391
| +67% | +$131K | 0.01% | 450 |
|
|
2019
Q3 | $183K | Buy |
2,062
+48
| +2% | +$4.16K | ﹤0.01% | 522 |
|
|
2019
Q2 | $166K | Buy |
2,014
+145
| +8% | +$11.4K | ﹤0.01% | 545 |
|
|
2019
Q1 | $151K | Sell |
1,869
-520
| -22% | -$41K | ﹤0.01% | 570 |
|
|
2018
Q4 | $181K | Sell |
2,389
-284
| -11% | -$22.2K | ﹤0.01% | 517 |
|
|
2018
Q3 | $212K | Buy |
2,673
+1,066
| +66% | +$80.6K | ﹤0.01% | 534 |
|
|
2018
Q2 | $113K | Sell |
1,607
-85
| -5% | -$6.12K | ﹤0.01% | 694 |
|
|
2018
Q1 | $118K | Sell |
1,692
-250
| -13% | -$17.3K | ﹤0.01% | 705 |
|
|
2017
Q4 | $135K | Sell |
1,942
-297
| -13% | -$20K | ﹤0.01% | 685 |
|
|
2017
Q3 | $152K | Sell |
2,239
-499
| -18% | -$31.5K | ﹤0.01% | 645 |
|
|
2017
Q2 | $187K | Buy |
2,738
+1,281
| +88% | +$83.7K | ﹤0.01% | 572 |
|
|
2017
Q1 | $91K | Sell |
1,457
-4,636
| -76% | -$270K | ﹤0.01% | 762 |
|
|
2016
Q4 | $333K | Sell |
6,093
-872
| -13% | -$49.5K | 0.01% | 513 |
|
|
2016
Q3 | $458K | Buy |
6,965
+5,842
| +520% | +$382K | 0.01% | 455 |
|
|
2016
Q2 | $68K | Sell |
1,123
-1,602
| -59% | -$93K | ﹤0.01% | 835 |
|
|
2016
Q1 | $373K | Sell |
2,725
-1,248
| -31% | -$75K | 0.01% | 482 |
|
|
2015
Q4 | $270K | Sell |
3,973
-1,150
| -22% | -$75.4K | 0.01% | 528 |
|
|
2015
Q3 | $326K | Buy |
5,123
+10
| +0.2% | +$658 | 0.01% | 505 |
|
|
2015
Q2 | $326K | Sell |
5,113
-337
| -6% | -$23.1K | 0.01% | 524 |
|
|
2015
Q1 | $373K | Sell |
5,450
-1,850
| -25% | -$129K | 0.01% | 485 |
|
|
2014
Q4 | $513K | Sell |
7,300
-40,650
| -85% | -$2.91M | 0.01% | 429 |
|
|
2014
Q3 | $3.43M | Sell |
47,950
-150
| -0.3% | -$11K | 0.07% | 285 |
|
|
2014
Q2 | $3.57M | Sell |
48,100
-62,500
| -57% | -$4.52M | 0.07% | 295 |
|
|
2014
Q1 | $7.18M | Buy |
110,600
+102,275
| +1,229% | +$6.61M | 0.14% | 180 |
|
|
2013
Q4 | $494K | Buy |
8,325
+325
| +4% | +$17.7K | 0.01% | 463 |
|
|
2013
Q3 | $415K | Hold |
8,000
| – | – | 0.01% | 476 |
|
|
2013
Q2 | $378K | Buy |
+8,000
| New | +$407K | 0.01% | 480 |
|
Other funds holding AZN
EP
IA
Huntington National Bank's AZN Position: Q2 2026 in Review
Huntington National Bank increased its AstraZeneca (AZN) stake by 26% in Q2 2026, buying an estimated $235K and bringing the position to 6,041 shares worth $1.15M. The position accounts for 0.01% of the portfolio, ranked #509.
Huntington National Bank first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.18M in Q1 2014. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Huntington National Bank held 6,041 shares of AstraZeneca worth $1.15M as of Q2 2026.
- Huntington National Bank bought 1,250 AstraZeneca shares in Q2 2026, an estimated $235K.
- AstraZeneca made up 0.01% of Huntington National Bank's portfolio in Q2 2026, its #509 holding.
- Huntington National Bank first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
- Huntington National Bank's AstraZeneca position peaked at $7.18M in Q1 2014.
- 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.